Biologically-active complexes and molecular magnets

Scientific News In Biologically-active Complexes and Molecular Magnets

National patent: Copper complexes with the 2-phenyl-3-hydroxyquinolin-4(1H)-one derivatives

29.02.2012 - 

The scientists from Palacký University in Olomouc have achieved further significant advancement in the research of novel highly effective potential anticancer drugs. In the national patent entitled “Copper complexes with the 2-phenyl-3-hydroxyquinolin-4(1H)-one derivatives, method of their preparation and use of these complexes as drugs in antitumour therapy” (CZ 303009 B6), which arose from the collaboration of the researchers from the Regional Centre of Advanced Technologies and Materials (RCPTM), Department of Inorganic Chemistry and Department of Cell Biology and Genetics, Faculty of Science, Palacký University, namely prof. Zdeněk Trávníček, Dr. Roman Buchtík, prof. Zdeněk Dvořák and Dr. Ján Vančo, the method of preparation of new compounds as well as their potential use as anticancer drugs is legally protected. The significant antitumour activity of the patented compounds was proved on a series of eight human cancer cell lines. These results of anticancer activity on cell models are so promising that the compounds will be further intensively studied on animal models and the mechanisms of their action will be studied on the molecular level. The studied compounds, thanks to their broad-spectrum cancerostatic action, have a potential to become an alternative to the commonly used platinum-based cytostatic drugs in the future.

Annual Scientific Conference of Regional Centre of Advanced Technologies and Materials

atom 24.11.2011 - 

We announce the first annual scientific conference of Regional Centre of Advanced Technologies and Materials. The conference is held on 25th November. The conference will be focused on scientifical results of the Centre. The conference will cover topics from all fields of interest in nanomaterial and optical research: Nanocrystalline oxides of transition metals in environmental, medical, catalytic, and optical applications; Carbon nanostructures, biomacromolecules and hybrid systems – synthesis, modeling of interaction and applications; Biologically-active compounds and molecular magnets on the basis of complexes of transition metals in interaction with nanocrystalline magnetic carriers; Advanced optical and photonic technologies; Advanced materials on the basis of nanoparticles of metals and metal hybrids with extraordinary reduction, antibacterial, sorption and catalytic properties; and Nanometric systems and nanotechnologies in new analytic approaches. The annual conference takes place at the hotel Akademie in Hrubá Voda (near to Olomouc) under the auspices of Prof. Radek Zbořil, Ph.D. , the General director of the Regional Centre of Advanced Technologies and Materials.

Head of the Division: Prof. Zdeněk Trávníček, Ph.D.

Scientific focus of the division:

  • Development of the new types of biologically active coordination compounds of the selected transition metals with high application potential in medicine and pharmacology (e.g. substances with antitumour, anti-inflammatory or antidiabetic activity).
  • Preparation and study of molecular magnets and molecular switches based on the transition metal complexes applicable as sensors or high density memory or recording media, etc.
  • Study of hybrid molecular-crystalline nanostructures with functionalized nanocrystalline iron oxide-based carriers with bound biologically active compound for the purpose of using these systems in targeted drug delivery or with magnetically interesting compound.
Single-crystal X-ray diffractometer (Xcalibur2)

Single-crystal X-ray diffractometer (Xcalibur2)

400 MHz NMR spectrometer

400 MHz NMR spectrometer

Molecular structure of the highly in vitro antitumour active platinum(II) complex and comparison of its activities with commercially used platinum-based anticancer drug cisplatin against seven human cancer cell lines

Molecular structure of the highly in vitro antitumour active platinum(II) complex and comparison of its activities with commercially used platinum-based anticancer drug cisplatin against seven human cancer cell lines

Results highlights – Patents:

Buchtík, R.; Dvořák, Z.; Trávníček, Z.; Vančo. J. Komplexy mědi s deriváty 2-fenyl-3-hydroxychinolin-4(1H)-onu, způsob jejich přípravy a použití těchto komplexů jako léčiv v protinádorové terapii. (CZ 303009 B6, udělen 11.1.2012)

Štarha, P.; Trávníček, Z.; Popa, I. Oxalátokomplexy platiny s deriváty N6-benzyladeninu, způsob jejich přípravy a použití těchto komplexů jako léčiv v protinádorové terapii (CZ 302623 B6, udělen 23.6.2011)

Dvořák, L.; Trávníček, Z.; Popa, I. Cyklobutan-1,1-dikarboxylátokomplexy platiny s deriváty N6-benzyladeninu, způsob jejich přípravy a použití těchto komplexů jako léčiv v protinádorové terapii (CZ 302618 B6, udělen 23.6.2011)

Results highlights – Publications:

Herchel, R.; Travnicek, Z. and Zboril, R. Tuning of the Critical Temperature in Iron(II) Spin-Crossover Materials Based on Bridging Polycyanidometallates: Pentacyanidonitrosylferrate(II) and Hexacyanidoplatinate(IV), < em>Inorg. Chem. 2011, 50, 12390–12392. Link

Nemec, I.; Herchel, R.; Boča, R.; Trávníček, Z.; Svoboda, I.; Fuess H. and Linert, W. Tuning of spin crossover behaviour in iron(III) complexes involving pentadentate Schiff bases and pseudohalides, Dalton Trans., 2011, 40, 10090–10099. Link
Buchtik, R.; Travnicek, Z.; Vanco, J.; Herchel, R. and Dvorak, Z. Synthesis, characterization, DNA interaction and cleavage, and in vitro cytotoxicity of copper(II) mixed-ligand complexes with 2-phenyl-3-hydroxy-4(1H)-quinolinone, Dalton Trans., 2011, 40, 9404–9412.Link
Herchel, R.; Tucek, J.; Travnicek, Z.; Petridis, D. and Zboril, R. Crystal Water Molecules as Magnetic Tuners in Molecular Metamagnets Exhibiting Antiferro-Ferro-Paramagnetic Transitions, Inorg. Chem. 2011, 50, 9153–9163.Link
Trávníček, Z.; Štarha, P.; Popa I.; Vrzal, R.; Dvořák, Z. Roscovitine-Based CDK Inhibitors Acting as N-Donor Ligands in the Platinum(II) Oxalato Complexes: Preparation, Characterization and In Vitro Cytotoxicity, Eur. J. Med. Chem., 2010, 45, 4609-4614.Link
Herchel, R.; Šindelář, Z.; Trávníček, Z.; Zbořil, R.; Vančo, J. Novel 1D Chain Fe(III)-salen-like Complexes Involving Anionic Heterocyclic N-Donor Ligands. Synthesis, X-ray Structure, Magnetic, 57Fe Mössbauer, and Biological Activity Studies, Dalton Trans. 2009, 9870-9880. Link
Štarha, P.; Trávníček, Z.; Popa I. Platinum(II) oxalato complexes with adenine-based carrier ligands showing significant in vitro antitumor activity, J. Inorg. Biochem. 2010, 104, 639–647.Link

Members of the division:


Name Title E-mail Phone Division
Trávníček Zdeněk prof., RNDr., Ph.D. zdenek.travnicek(at)upol.cz +420585634352 Complexes
Popa Igor Mgr., CSc. igor.popa(at)upol.cz +420585634497 Complexes
Štarha Pavel Mgr., Ph.D. pavel.starha(at)upol.cz +420585634349 Complexes
Vančo Ján PharmDr., Ph.D. vancoj(at)vfu.cz Complexes
Nemec Ivan Ing., Ph.D. ivan.nemec(at)upol.cz +420585634354 Complexes
Novotná Radka Mgr. radka.novotna(at)upol.cz +420585634355 Complexes
Dvořák Zdeněk prof., RNDr., Ph.D. zdenek.dvorak(at)upol.cz +420585634903 Complexes
Drahoš Bohuslav Mgr. Complexes
Hošek Jan RNDr., Ph.D. jan.hosek(at)upol.cz Complexes
Herchel Radovan Mgr., Ph.D. radovan.herchel@upol.cz +420585634435 Complexes